CME Group thrives on market volatility with innovative derivatives, global growth, and strong financials, offering stability, ...

Analysts have set 12-month price targets for CME Group, revealing an average target of $266.18, a high estimate of $305.00, ...

What Happened: Gerdes's decision to sell 4,000 shares of CME Group was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the sale is $1,060,441 ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

With an ROA of 0.64%, the company may face hurdles in achieving optimal financial performance. Debt Management: CME Group's debt-to ... Analysts typically rate each stock once per quarter.

In the first quarter of 2025, CME Group reported total revenues of $1,642.3 million, marking a 10% increase from the same ...

DGRO boasts a low expense ratio, strong liquidity, and a healthy dividend yield. See why I think the fund is a buy.

CME Group (CME) came out with quarterly ... the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Securities and ...

Besides Wall Street's top -and-bottom-line estimates for CME (CME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ...

The company’s strong performance is reflected in its impressive ... though InvestingPro analysis indicates the stock is currently trading slightly above its Fair Value. CME Group, known for its ...

The company’s strong performance is reflected ... though InvestingPro analysis indicates the stock is currently trading slightly above its Fair Value. CME Group, known for its diverse risk ...